Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.78 |
| ▸ | ACHE | P22303 | 1/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | MET | P08581 | 2/20 | 0.68 |
| ▸ | CNR2 | P34972 | 1/20 | 0.66 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA4 | P22748 | 1/20 | 0.64 |
| ▸ | CA6 | P23280 | 1/20 | 0.64 |
| ▸ | HTR7 | P34969 | 1/20 | 0.64 |
| ▸ | CA5A | P35218 | 1/20 | 0.64 |
| ▸ | CA7 | P43166 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 2/20 | 0.63 |
| ▸ | MAOB | P27338 | 2/20 | 0.63 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.63 |
| ▸ | KDM1A | O60341 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Trans-Feruloyl Tyramine SCHEMBL17693085 | 0.93 | TYR (0.83) | TYRACHEMETCNR2CA12 | |
| N-Trans-Feruloyl Tyramine SCHEMBL1675910 | 0.93 | TYR (0.83) | TYRACHEMETCNR2CA12 | |
| N-Trans-Feruloyl Tyramine SCHEMBL30069091 | 0.93 | TYR (0.83) | TYRACHEMETCNR2CA12 | |
| N-Trans-Feruloyl Tyramine SCHEMBL2378679 | 0.93 | TYR (0.83) | TYRACHEMETCNR2CA12 | |
| N-Trans-Feruloyl Tyramine SCHEMBL29477339 | 0.93 | TYR (0.83) | TYRACHEMETCNR2CA12 | |
| Terrestribisamide SCHEMBL10735557 | 0.88 | TYR (1.00) | TYRACHEKDM4EALDH1A1CA12 | |
| Terrestribisamide SCHEMBL30382198 | 0.88 | TYR (1.00) | TYRACHEKDM4EALDH1A1CA12 | |
| Terrestribisamide SCHEMBL31278144 | 0.88 | TYR (1.00) | TYRACHEKDM4EALDH1A1CA12 | |
| SCHEMBL802998 | 0.86 | ACHE (0.79) | TYRACHEKDM4EALDH1A1MAOA | |
| SCHEMBL1917145 | 0.86 | TYR (0.91) | TYRACHEKDM4EALDH1A1MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10450271-B2 | Compounds for inhibition of fungal toxin production | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2019-10-22 | — | — | US | disclosed |
| US-9988352-B2 | Compounds for inhibition of fungal toxin production | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2018-06-05 | — | — | US | disclosed |
| US-20170183309-A1 | COMPOUNDS FOR INHIBITION OF FUNGAL TOXIN PRODUCTION | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2017-06-29 | — | — | US | disclosed |
| WO-2015188136-A1 | COMPOUNDS FOR INHIBITION OF FUNGAL TOXIN PRODUCTION | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2015-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450271-B2 | Compounds for inhibition of fungal toxin production | ERG28, CYP51A1, ETF1 | TYR 35/4885ACHE 3823/4885KDM4E 1747/4885 |
| US-20170183309-A1 | COMPOUNDS FOR INHIBITION OF FUNGAL TOXIN PRODUCTION | ERG28, CYP51A1, ETF1 | TYR 35/4885ACHE 3823/4885KDM4E 1747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.